Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

US10501550B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Changyu Wang · Union City, US
• Nils Lonberg · Woodside, US
• Alan J. Korman · Piedmont, US
• Mark J. Selby · San Francisco, US
• Mohan Srinivasan · Cupertino, US
• Karla A. HENNING · Milpitas, US
• Michelle Minhua HAN · Piedmont, US
• Guodong Chen · East Brunswick Township, US
• Richard Y. Huang · Princeton, US
• Indrani Chakraborty · Fremont, US
• Haichun Huang · Fremont, US
• Susan WONG · Fremont, US
• Huiming LI · Lexington, US

Key dates

• Filing date: Dec 5, 2016
• Grant date: Dec 10, 2019
• Expiry date: Dec 5, 2036

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2333/7151
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are antibodies, or antigen binding portions thereof, that bind to glucocorticoid-inducible TNF receptor (GITR). Also provided are uses of these proteins in therapeutic applications, such as in the treatment of cancer. Further provided are cells that produce antibodies, polynucleotides encoding the heavy and/or light chain variable region of the antibodies, and vectors comprising the polynucleotides encoding the heavy and/or light chain variable region of the antibodies.